The translational biology of remyelination: Past, present, and future

GLIA

Volumn 62, Issue 11, 2014, Pages 1905-1915

  Franklin, Robin J M ^a   Gallo, Vittorio ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Multiple sclerosis; Progenitor; Remyelination

Indexed keywords

CELL FUNCTION; CELL REGENERATION; CELL TRANSPLANTATION; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL; OLIGODENDROGLIA; REGENERATIVE MEDICINE; REMYELINIZATION; REVIEW; STEM CELL; ANIMAL; DEMYELINATING DISEASES; GLIA; HISTORY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; TRANSLATIONAL RESEARCH; TRENDS;

ANIMALS; DEMYELINATING DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEUROGLIA; NEURONS; REGENERATION; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84904329951     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22622     Document Type: Review

References (131)

1. Aguirre AA, Chittajallu R, Belachew S, Gallo V. 2004. NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus. J Cell Biol 165:575-589.
2. Aguirre A, Dupree JL, Mangin JM, Gallo V. 2007. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci 10:990-1002.
3. Armendáriz BG, Bribian A, Pérez-Martínez E, Martínez A, de Castro F, Soriano E, Burgaya F. 2012. Expression of Semaphorin 4F in neurons and brain oligodendrocytes and the regulation of oligodendrocyte precursor migration in the optic nerve. Mol Cell Neurosci 49:54-67.
4. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJM, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
5. Atanasoski S, Boentert M, De Ventura L, Pohl H, Baranek C, Beier K, Young P, Barbacid M, Suter U. 2008. Postnatal Schwann cell proliferation but not myelination is strictly and uniquely dependent on cyclin-dependent kinase 4 (cdk4). Mol Cell Neurosci 37:519-527.
6. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458-468.
7. Belachew S, Aguirre AA, Wang H, Vautier F, Yuan X, Anderson S, Kirby M, Gallo V. 2002. Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J Neurosci 22:8553-8562.
8. Bergles DE, Roberts JD, Somogy P, Jahr CE. 2000. Glutamatergic synapses on oligodendrocyte precursor cells. Nature 405:187-191.
9. Black JA, Liu S, Hains BC, Saab CY, Waxman SG. 2006. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 129:3196-3208.
10. Caillava C, Vandenbosch R, Jablonska B, Deboux C, Spigoni G, Gallo V, Malgrange B, Baron-Van Evercooren A. 2011. Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system. J Cell Biol 193:397-407.
11. Cannella B, Gaupp S, Omari KM, Raine CS. 2007. Multiple sclerosis: Death receptor expression and oligodendrocyte apoptosis in established lesions. J Neuroimmunol 188:128-337.
12. Caprariello AV, Mangla S, Miller RH, Selkirk SM. 2012. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. Ann Neurol 72:395-405.
13. Carroll WM, Jennings AR, Ironside LJ. 1998. Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination. Brain 121:293-302.
14. Cassiani-Ingoni R, Coksaygan T, Xue H, Reichert-Scrivner SA, Wiendl H, Rao MS, Magnus T. 2006. Cytoplasmic translocation of Olig2 in adult glial progenitors marks the generation of reactive astrocytes following autoimmune inflammation. Exp Neurol 201:349-358.
15. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New Engl J Med 346:165-173.
16. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B, Lubetzki C. 2000. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 97:7585-7590.
17. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C. 2002. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor of remyelination in multiple sclerosis? Brain 125:1972-1979.
18. Coman I, Aigrot MS, Seilhean D, Reynolds R, Girault JA, Zalc B, Lubetzki C. 2006. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain 129:3186-3195.
19. Coman I, Barbin G, Charles P, Zalc B, Lubetzki C. 2005. Axonal signals in central nervous system myelination, demyelination and remyelination. J Neurol Sci 233:67-71.
20. Craner MJ, Hains BC, Lo AC, Black JA, Waxman SG. 2004. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 127:294-303.
21. Craner MJ, Lo AC, Black JA, Waxman SG. 2003. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain 126:1552-1561.
22. Crawford DK, Mangiardi M, Tiwari-Woodruff SK. 2009. Assaying the functional effects of demyelination and remyelination: Revisiting field potential recordings. J Neurosci Methods 182:25-33.
23. Cui QL, Kuhlmann T, Miron VE, Leong SY, Fang J, Gris P, Kennedy TE, Almazan G, Antel J. 2013. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis. Am J Pathol 183:516-525.
24. De Biase LM, Nishiyama A, Bergles DE. 2010. Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci 30:3600-3611.
25. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C. 1996. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA 93:9887-9892.
26. Dobson NR, Zhou YX, Flint NC, Armstrong RC. 2008. Musashi1 RNA-binding protein regulates oligodendrocyte lineage cell differentiation and survival. Glia 56:318-330.
27. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703-716.
28. Dubois-Dalcq M, ffrench-Constant C, Franklin RJM. 2005. Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48:9-12.
29. Duncan ID, Browerb A, Kondoa Y, Curlee JF Jr., Schultz RD. 2009. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci USA 106:6832-6836.
30. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD. 2006. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478-489.
31. Eriksson C, Bjorklund A, Wictorin K. 2003. Neuronal differentiation following transplantation of expanded mouse neurosphere cultures derived from different embryonic forebrain regions. Exp Neurol 184:615-635.
32. Etxeberria A, Mangin JM, Aguirre A, Gallo V. 2010. Adult-born SVZ progenitors receive transient glutamatergic synapses during remyelination of the corpus callosum. Nat Neurosci 13:287-289.
33. Fancy SPJ, Baranzini SE, Zhao C, Irvine K-A, Kaing S, Sanai N, Franklin RJM, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571-1585.
34. Fancy SPJ, Zhao C, Franklin RJM. 2004. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27:247-254.
35. Ferent J, Zimmer C, Durbec P, Ruat M, Traiffort E. 2013. Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J Neurosci 33:1759-1772.
36. Franklin RJM, ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9:839-855.
37. Franklin RJM, ffrench-Constant C, Edgar J, Smith K. 2012. Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol 8:623-634.
38. Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave KA, Schneider A, Simons M, Klugmann M, Trotter J, Krämer-Albers EM. 2013. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11:e1001604.
39. Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA. 2012. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517-521.
40. Gallo V, Armstrong RC. 2008. Myelin repair strategies: A cellular view. Curr Opin Neurol 21:278-283.
41. Gallo V, Mangin JM, Kukley M, Dietrich D. 2008. Synapses on NG2-expressing progenitors in the brain: Multiple functions? J Physiol 586:3767-3781.
42. Gallo V, Zhou JM, McBain C, Wright P, Knutson PL, Armstrong RC. 1996. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci 16:2659-2670.
43. Ganat YM, Silbereis J, Cave C, Ngu H, Anderson GM, Ohkubo Y, Ment LR, Vaccarino FM. 2006. Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo. J Neurosci 26:8609-8621.
44. Ganter P, Prince C, Esiri MM. 1999. Spinal cord axonal loss in multiple sclerosis: A post-mortem study. Neuropathol Appl Neurobiol 25:459-467.
45. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
46. Ge WP, Zhou W, Luo Q, Jan LY, Jan YN. 2009. Dividing glial cells maintain differentiated properties including complex morphology and functional synapses. Proc Natl Acad Sci USA 106:328-333.
47. Gensert JM, Goldman JE. 1997. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19:197-203.
48. Goldman SA, Nedergaard M, Windrem MS. 2012. Glial progenitor cell-based treatment and modeling of neurological disease. Science 338:491-495.
49. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T. 2009. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72:1914-1921.
50. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
51. Groves AK, Barnett SC, Franklin RJM, Crang AJ, Mayer M, Blakemore WF, Noble M. 1993. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362:453-455.
52. Guo F, Maeda Y, Ma J, Delgado M, Sohn J, Miers L, Ko EM, Bannerman P, Xu J, Wang Y, Zhou C, Takebayashi H, Pleasure D. 2011. Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis. J Neurosci 31:11914-11928.
53. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, Caverzasi E, Gaetano L, Mandelli ML, Ryan T, Perry R, Farrell J, Jeremy RJ, Ulman M, Huhn SL, Barkovich AJ, Rowitch DH. 2012. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med 4:155ra137.
54. Hampton DW, Innes N, Merkler D, Zhao C, Franklin RJM, Chandran S. 2012. Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency. Am J Pathol 180:1897-1905.
55. Horsfield MA. 2005. Magnetization transfer imaging in multiple sclerosis. J Neuroimaging 15:58S-67S.
56. Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Baron van Evercooren A, Chambon P, ffrench-Constant C, Franklin RJM. 2011. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 14:45-53.
57. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD. 2006. Astrocytes promote myelination in response to electrical impulses. Neuron 49:823-832.
58. Itoyama Y, Webster HD, Richardson EP Jr, Trapp BD. 1983. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 14:339-346.
59. Jablonska B, Aguirre A, Raymond M, Szabo G, Kitabatake Y, Sailor KA, Ming GL, Song H, Gallo V. 2010. Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat Neurosci 13:541-550.
60. Jessberger S, Gage FH. 2009. Fate plasticity of adult hippocampal progenitors: Biological relevance and therapeutic use. Trends Pharmacol Sci 30:61-65.
61. Jessberger S, Toni N, Clemenson GD Jr, Ray J, Gage FH. 2008. Directed differentiation of hippocampal stem/progenitor cells in the adult brain. Nat Neurosci 11:888-893.
62. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. 2010. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68:668-681.
63. Kang X, Herron TJ, Woods DL. 2011. Regional variation, hemispheric asymmetries and gender differences in pericortical white matter. Neuroimage 56:2011-2023.
64. Káradóttir R, Cavelier P, Bergersen LH, Attwell D. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162-1166.
65. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
66. Kucharova K, Chang Y, Boor A, Yong VW, Stallcup WB. 2011.Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord. J Neuroinflammation 13:158.
67. Kukley M, Capetillo-Zarate E, Dietrich D. 2007. Vesicular glutamate release from axons in white matter. Nat Neurosci 10:311-320.
68. Kukley M, Kiladze M, Tognatta R, Hans M, Swandulla D, Schramm J, Dietrich D. 2008. Glial cells are born with synapses. FASEB J 8:2957-2969.
69. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
70. Lasiene J, Shupe L, Perlmutter S, Horner P. 2008. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci 28:3887-3896.
71. Laule C, Vavasour IM, Kolind SH, Li DK, Traboulsee TL, Moore GR, MacKay AL. 2007. Magnetic resonance imaging of myelin. Neurotherapeutics 4:460-484.
72. Laywell E, Rakic P, Kukekov VG, Holland EC, Steindler DA. 2000. Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci USA 97:13883-13888.
73. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-448.
74. Levine JM, Reynolds R. 1999. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp Neurol 160:333-347.
75. Levison SW, Goldman JE. 1993. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 10:201-212.
76. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitch DH. 2006. Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci USA 103:7853-78588.
77. Lin SC, Bergles DE. 2004. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci 7:24-32.
78. Liu J, Dietz K, DeLoyht JM, Pedre X, Kelkar D, Kaur J, Vialou V, Lobo MK, Dietz DM, Nestler EJ, Dupree J, Casaccia P. 2012. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat Neurosci 15:1621-1623.
79. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109:75-86.
80. Makinodan M, Rosen KM, Ito S, Corfas G. 2012. A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 337:1357-1360.
81. Mangin JM, Li P, Scafidi J, Gallo V. 2012. Experience-dependent regulation of NG2 progenitors in the developing barrel cortex. Nat Neurosci 15:1192-1194.
82. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. 2002. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 22:10333-10345.
83. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK. 2004. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164:1673-1682.
84. Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A. 2006. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26:7907-7918.
85. Mi S, Lee X, Hu Y, Ji B, Shao Z, Yang W, Huang G, Walus L, Rhodes K, Gong BJ, Miller RH, Pepinsky RB. 2011. Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat Med 17:816-821.
86. Ming X, Chew LJ, Gallo V. 2013. Transgenic over-expression of Sox17 promotes oligodendrocyte development and attenuates demyelination. J Neurosci 33:12528-12542.
87. Moll NM, Hong E, Faveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew L-J, Gallo V, Nait-Oumesmar B. 2013. Sox17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Glia 61:1659-1672
88. Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Baron-Van Evercooren A. 1999. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 11:4357-4366.
89. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Höglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. 2007. Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors. Proc Natl Acad Sci USA 104:4694-4699.
90. Najm FJ, Lager AM, Zaremba A, Wyatt K, Caprariello AV, Factor DC, Karl RT, Maeda T, Miller RH, Tesar PJ. 2013. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol 31:426-433.
91. Nakatani H, Martin E, Hassani H, Clavairoly A, Maire CL, Viadieu A, Kerninon C, Delmasure A, Frah M, Weber M, Nakafuku M, Zalc B, Thomas JL, Guillemot F, Nait-Oumesmar B, Parras C. 2013. Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelination. J Neurosci 33:9752-9768.
92. Nave KA. 2010. Myelination and the trophic support of long axons. Nat Rev Neurosci 11:275-283.
93. Parras CM, Galli R, Britz O, Soares S, Galichet C, Battiste J, Johnson JE, Nakafuku M, Vescovi A, Guillemot F. 2004. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. EMBO J 23:4495-4505.
94. Pasterkamp RJ. 2012. Getting neural circuits into shape with semaphorins. Nat Rev Neurosci 13:605-618.
95. Patneau DK, Wright P, Winters C, Mayer ML, Gallo V. 1994. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12:357-371.
96. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129:3165-3172.
97. Penderis J, Shields SA, Franklin RJM. 2003. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126:1382-1391.
98. Piaton G, Aigrot MS, Williams A, Moyon S, Tepavcevic V, Moutkine I, Gras J, Matho KS, Schmitt A, Soellner H, Huber AB, Ravassard P, Lubetzki C. 2011. Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134:1156-1167.
99. Powers BE, Sellers DL, Lovelett EA, Cheung W, Aalami SP, Zapertov N, Maris DO, Horner PJ. 2013. Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin. Proc Natl Acad Sci USA 110:4075-4080.
100. Rafalski VA, Ho PP, Brett JO, Ucar D, Dugas JC, Pollina EA, Chow LM, Ibrahim A, Baker SJ, Barres BA, Steinman L, Brunet A. 2013. Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nat Cell Biol 15:614-624.
101. Rhodes KE, Raivich G, Fawcett JW. 2006. The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines. Neurosci 140:87-100.
102. Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJM. 2012. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10:96-103.
103. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJM, Casaccia-Bonnefil P. 2008. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11:1024-1034.
104. Smith CM, Cooksey E, Duncan ID. 2013. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J Neurosci 33:2718-2727.
105. Smith KJ. 2007. Sodium channels and multiple sclerosis: Roles in symptom production, damage and therapy. Brain Pathol 17:230-242.
106. Soula C, Danesin C, Kan P, Grob M, Poncet C, Cochard P. 2001. Distinct sites of origin of oligodendrocytes and somatic motoneurons in the chick spinal cord: Oligodendrocytes arise from Nkx2.2-expressing progenitors by a Shh-dependent mechanism. Development 128:1369-1379.
107. Stankoff B, Freeman L, Aigrot MS, Chardain A, Dollé F, Williams A, Galanaud D, Armand L, Lehericy S, Lubetzki C, Zalc B, Bottlaender M. 2011. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4'-methylaminophenyl)-6-hydroxybenzothiazole. Ann Neurol 69:673-680.
108. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. 2002. Adenosine: A neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:1-20.
109. Stys PK, Waxman SG, Ransom BR. 1992. Ionic mechanisms of anoxic injury in mammalian CNS white matter: Role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci 12:430-439.
110. Syed YA, Hand E, Möbius W, Zhao C, Hofer M, Nave KA, Kotter MR. 2011. Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci 31:3719-3728.
111. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Eng J Med 338:278-285.
112. Vana AC, Lucchinetti CF, Le TQ, Armstrong RC. 2007. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS. Glia 55:687-697.
113. Wake H, Lee PR, Fields RD. 2011. Control of local protein synthesis and initial events in myelination by action potentials. Science 333:1647-1651.
114. Watanabe M, Hadzic T, Nishiyama A. 2004. Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia 46:311-322.
115. Watanabe M, Toyama Y, Nishiyama A. 2002. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69:826-836.
116. Waxman S. 2006. Axonal conduction and injury in multiple sclerosis: The role of sodium channels. Nat Rev Neurosci 7:932-941.
117. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Möbius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave KA. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27:7717-7730.
118. Whitman LM, Blanc CA, Schaumburg CS, Rowitch DH, Lane TE. 2012. Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination. Exp Neurol 235:380-387.
119. Wilkins A, Majed H, Layfield R, Compston A, Chandran S. 2003. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: A novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 23:4967-4974.
120. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G II, Roy NS, Goldman SA. 2004. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10:93-97.
121. Woodruff RH, Franklin RJM. 1999. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination. Neurobiol Appl Neurobiol 25:226-235.
122. Yanagisawa M, Nakashima K, Ochiai W, Takizawa T, Setoguchi T, Uemura A, Takizawa M, Nobuhisa I, Taga T. 2005. Fate redirection of hippocampal astrocytes toward neuronal lineage by aggregate culture. Neurosci Res 53:176-182.
123. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR. 2009. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12:829-838.
124. Yuan X, Eisen AM, McBain CJ, Gallo V. 1998. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125:2901-2914.
125. Zambonin JL, Zhao C, Ohno N, Campbell GR, Engeham S, Ziabreva I, Schwarz N, Lee SE, Frischer JM, Turnbull DM, Trapp BD, Lassmann H, Franklin RJM, Mahad DJ. 2011. Increased mitochondrial content in remyelinated axons: Implications for multiple sclerosis. Brain 134:1901-1913.
126. Zatorre RJ, Fields RD, Johansen-Berg H. 2012. Plasticity in gray and white: Neuroimaging changes in brain structure during learning. Net Neurosci 15:528-536.
127. Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson WD, Franklin RJM. 2010. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6:578-590.
128. Zhou Q, Choi G, Anderson DJ. 2001. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 31:791-807.
129. Zhou YX, Pannu R, Le TQ, Armstrong RC. 2012. Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination. Neurobiol Dis 45:196-205.
130. Zhu X, Bergles DE, Nishiyama A. 2008. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135:145-157.
131. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles D. 2007. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10:321-330.